(Q48663985)

14 February 2018

title

Gender but not stimulus parameters influence prolactin response to electroconvulsive therapy. (English)

1 reference

14 February 2018

author

Bengaluru Gangadhar

4

1 reference

14 February 2018

author name string

Motreja S

1

1 reference

14 February 2018

Subbakrishna DK

2

1 reference

14 February 2018

Subhash MN

3

1 reference

14 February 2018

Janakiramaiah N

5

1 reference

14 February 2018

Parameshwara G

6

1 reference

14 February 2018

publication date

1 July 1997

1 reference

14 February 2018

number of pages

12

1 reference

inferred from page(s)

published in

Psychoneuroendocrinology

1 reference

14 February 2018

volume

22

1 reference

14 February 2018

page(s)

337-348

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Prolactin and thyrotropin in serum during electroconvulsive therapy in patients with major depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Studies on the prolactin response induced by electroconvulsive therapy in schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Hormone response to repeated electroconvulsive therapy: effects of naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Convulsive threshold differences in right unilateral and bilateral ECT

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Prolactin response to repeated electroconvulsive therapy in acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Prolactin changes during electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Prolactin response to electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Increases in prolactin levels following bilateral and unilateral ECT

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Electrophysiological and hormonal responses to three types of electroconvulsive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Repeated ECT and prolactin release in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Electroconvulsive therapy (ECT) increases plasma growth hormone, prolactin, luteinising hormone and follicle-stimulating hormone but not thyrotropin or substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Prolactin levels after bilateral and unilateral ECT

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Serum prolactin in epilepsy and hysteria

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

Selective effects of ECT on hypothalamic-pituitary activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900034-6

7 January 2021

10.1016/S0306-4530(97)00034-6

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9279939

1 reference

14 February 2018